April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Hidehito Horinouchi: iDFS reliably predicts final OS in breast cancer
Feb 7, 2025, 14:07

Hidehito Horinouchi: iDFS reliably predicts final OS in breast cancer

Hidehito Horinouchi, Assistant Chief of the National Cancer Center Hospital, shared a post on X about a recent paper by Fabio Conforti et al. published in the Journal of Clinical Oncology:

“Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast Cancer.

iDFS is an acceptable surrogate endpoint to confidently anticipate the final OS.

Dr. Fabio Conforti.”

“Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast Cancer”

Authors: Fabio Conforti, Valentina Nekljudova, Isabella Sala, Richard Gelber, Sibylle Loibl et al.

Hidehito Horinouchi: iDFS reliably predicts final OS in breast cancer

More posts featuring Hidehito Horinouchi.